181 related articles for article (PubMed ID: 25887997)
1. Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls.
Shen Y; Zhang J; Cai H; Shao JG; Zhang YY; Liu YM; Qin G; Qin Y
BMC Gastroenterol; 2015 Mar; 15():32. PubMed ID: 25887997
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Diabetes Mellitus and Cirrhosis Risk in Chronic Hepatitis B Patients in Wuhan, China.
Xu C; Chen J; Zhang PA
Med Sci Monit; 2019 Oct; 25():8112-8119. PubMed ID: 31661471
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinical and pathological features of chronic hepatitis B combined with metabolic-associated fatty liver disease].
Shang MY; Chen YZ; Bao J; Tong YL
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):126-132. PubMed ID: 37137826
[No Abstract] [Full Text] [Related]
6. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.
Minakari M; Molaei M; Shalmani HM; Mohammad Alizadeh AH; Jazi AH; Naderi N; Shavakhi A; Mashayekhi R; Zali MR
Eur J Gastroenterol Hepatol; 2009 May; 21(5):512-6. PubMed ID: 19190500
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection.
Sefa Sayar M; Bulut D; Acar A
Arab J Gastroenterol; 2023 Feb; 24(1):11-15. PubMed ID: 35688683
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
Yu MW; Lin CL; Liu CJ; Huang YW; Hu JT; Wu WJ; Wu CF
J Formos Med Assoc; 2022 Aug; 121(8):1478-1487. PubMed ID: 34764005
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
Peng D; Han Y; Ding H; Wei L
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
13. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
[TBL] [Abstract][Full Text] [Related]
14. Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study.
Su MH; Lu AL; Li SH; Zhong SH; Wang BJ; Wu XL; Mo YY; Liang P; Liu ZH; Xie R; He LX; Fu WD; Jiang JN
World J Gastroenterol; 2015 Dec; 21(46):13087-94. PubMed ID: 26673249
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
[TBL] [Abstract][Full Text] [Related]
16. Association between hepatitis B and metabolic syndrome: Current state of the art.
Jarcuska P; Drazilova S; Fedacko J; Pella D; Janicko M
World J Gastroenterol; 2016 Jan; 22(1):155-64. PubMed ID: 26755867
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes.
Lu J; Hou X; Tu H; Tang Z; Xiang Y; Bao Y; Gu J; Jia W
J Diabetes Investig; 2017 Jul; 8(4):619-625. PubMed ID: 27930871
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
20. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]